drugset / Trial / NCT02626234
A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
the study aim to assess the effect of INC280 on the pharmacokinetics of digoxin and rosuvastatin in patients with cMET-dysregulated advanced solid tumors
Timeline
- Start
- 2015-12-08
- Primary completion
- 2017-02-28
- Completion
- 2017-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capmatinib | Small molecule | — | — |
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.